Shanghai RAAS Blood Products (002252.SZ) - EPS (earnings per share)

EPS in 2025 (TTM): S$0.07504

According to Shanghai RAAS Blood Products's latest financial reports the company's current EPS (TTM) is S$0.07195. In 2024 the company made an earnings per share (EPS) of S$0.05824 an increase over its 2023 EPS that were of S$0.04920.

EPS history for Shanghai RAAS Blood Products from 2005 to 2025

Annual EPS

Year	EPS	Change
2025 (TTM)	S$0.07504	28.84%
2024	S$0.05824	18.38%
2023	S$0.04920	-5.91%
2022	S$0.05229	36.15%
2021	S$0.03840	-7.39%
2020	S$0.04147	87.44%
2019	S$0.02212	-138.11%
2018	S-$0.05806	-272.5%
2017	S$0.03366	-45.02%
2016	S$0.06121	5.85%
2015	S$0.05783	127.47%
2014	S$0.02542	48.29%
2013	S$0.01714	29.9%
2012	S$0.01320	13.1%
2011	S$0.01167	14.18%
2010	S$0.01022	40.49%
2009	S$0.007275	13.05%
2008	S$0.006435	18.08%
2007	S$0.005450	-37.8%
2006	S$0.008762	2.48%
2005	S$0.008550

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

EPS for Shanghai RAAS Blood Products (002252.SZ)